What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.24%Below 5Y avg (2.42%)
Annual Rate
JPY 50.00Paid annual
Payout Ratio
97.1%High
Next Ex-Dividend
Mar 12, 2027
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
67.56BJPY
423.06M · vs all stocks (USD)
Updated Nov 22, 2026
Trailing P/E
30.12x
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Revenue (TTM)
283.28BJPY
1.79B · vs all stocks (USD)
Updated Nov 22, 2026
Profit Margin
1.05%
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Beta
0.1640x
vs all stocks
Updated Nov 22, 2026
52-Week Change
31.01%
vs all stocks
Updated Nov 22, 2026
Market Capitalization
67.56BJPY
423.06M · vs all stocks (USD)
Updated Nov 22, 2026
Enterprise Value
61.33BJPY
388.96M · vs all stocks (USD)
Updated Nov 22, 2026
Trailing P/E
30.12x
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Price to Sales (TTM)
0.3105x
vs Pharmaceutical Retailers peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.24×.Updated Nov 22, 2026
Price to Book (MRQ)
0.7716x
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Enterprise to Revenue
0.2170x
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Enterprise to EBITDA
5.57x
vs Pharmaceutical Retailers peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 4.89×.Updated Nov 22, 2026
Profit Margin
1.05%
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Operating Margin
2.30%
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Return on Assets (TTM)
2.02%
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Return on Equity (TTM)
2.61%
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Revenue (TTM)
283.28BJPY
1.79B · vs all stocks (USD)
Updated Nov 22, 2026
Revenue per Share (TTM)
12.70KJPYUpdated Nov 22, 2026
Quarterly Revenue Growth
-2.90%
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Gross Profit (TTM)
65.13BJPY
410.27M · vs all stocks (USD)
Updated Nov 22, 2026
EBITDA (TTM)
12.55BJPY
78.57M · vs all stocks (USD)
Updated Nov 22, 2026
Net Income (TTM)
2.99BJPY
20.40M · vs all stocks (USD)
Updated Nov 22, 2026
Quarterly Earnings Growth (YoY)
-19.10%
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Operating Cash Flow (TTM)
10.28BJPY
55.51M · vs all stocks (USD)
Updated Nov 22, 2026
Levered Free Cash Flow (TTM)
5.06BJPY
20.04M · vs all stocks (USD)
Updated Nov 22, 2026
Trailing Annual Dividend Rate
50.00JPYUpdated Nov 22, 2026
Trailing Annual Dividend Yield
1.24%
vs all stocks
Updated Nov 22, 2026
5-Year Average Dividend Yield
2.42%
vs all stocks
Updated Nov 22, 2026
Payout Ratio
97.05%
vs Pharmaceutical Retailers peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 37.33%.Updated Nov 22, 2026
Revenue
284.49BJPYFY2026 · Mar 31, 2026
Cost of Goods Sold
219.17BJPYFY2026 · Mar 31, 2026
Gross Profit
65.32BJPYFY2026 · Mar 31, 2026
Operating Income
6.78BJPY
42.46M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Pre-tax Income
5.57BJPYFY2026 · Mar 31, 2026
Income Tax Expense
2.37BJPYFY2026 · Mar 31, 2026
Net Income
3.20BJPYFY2026 · Mar 31, 2026
EBIT
5.64BJPYFY2026 · Mar 31, 2026
EBITDA (Income Statement)
12.55BJPYFY2026 · Mar 31, 2026
Non-operating Interest Income
23.00MJPYFY2026 · Mar 31, 2026
Non-operating Interest Expense
70.00MJPYFY2026 · Mar 31, 2026
EPS (Basic)
143.30JPYFY2026 · Mar 31, 2026
EPS (Diluted)
143.14JPYFY2026 · Mar 31, 2026
Basic Shares Outstanding
22.33MSharesFY2026 · Mar 31, 2026
Diluted Shares Outstanding
22.33MSharesFY2026 · Mar 31, 2026
Preferred Stock Dividends
0.00JPYFY2026 · Mar 31, 2026
Operating Cash Flow
4.34BJPYFY2026 · Mar 31, 2026
Free Cash Flow
147.00MJPYFY2026 · Mar 31, 2026
Cash & Cash Equivalents (End of Period)
38.11BJPYFY2026 · Mar 31, 2026
Starting Profit (CF Statement)
5.57BJPYFY2026 · Mar 31, 2026
Other Non-cash Items
41.00MJPYFY2026 · Mar 31, 2026
Change in Accounts Receivable (CF)
-1.11BJPYFY2026 · Mar 31, 2026
Change in Other Assets/Liabilities
-164.00MJPYFY2026 · Mar 31, 2026
Capital Expenditures
-4.20BJPYFY2026 · Mar 31, 2026
Net Intangibles (CF)
-114.00MJPYFY2026 · Mar 31, 2026
Other Investing Activity
-846.00MJPYFY2026 · Mar 31, 2026
Net Investing Cash Flow
-5.04BJPYFY2026 · Mar 31, 2026
Long-term Debt Issuance
5.90BJPYFY2026 · Mar 31, 2026
Long-term Debt Payments
-6.38BJPYFY2026 · Mar 31, 2026
Common Dividends Paid
-1.78BJPYFY2026 · Mar 31, 2026
Other Financing Charges
-1.00MJPYFY2026 · Mar 31, 2026
Net Financing Cash Flow
-2.27BJPYFY2026 · Mar 31, 2026
Shares Outstanding
21.80MSharesUpdated Nov 22, 2026
Float Shares
12.10MSharesUpdated Nov 22, 2026
% Held by Insiders
39.71%
vs all stocks
Updated Nov 22, 2026
% Held by Institutions
17.07%
vs all stocks
Updated Nov 22, 2026
Total Cash (MRQ)
41.61BJPY
279.46M · vs all stocks (USD)
Updated Nov 22, 2026
Total Cash per Share (MRQ)
1.91KJPYUpdated Nov 22, 2026
Total Debt (MRQ)
14.97BJPY
103.40M · vs all stocks (USD)
Updated Nov 22, 2026
Total Debt to Equity (MRQ)
0.1313x
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Current Ratio (MRQ)
1.49x
vs Pharmaceutical Retailers peers
Updated Nov 22, 2026
Book Value per Share (MRQ)
5.23KJPYUpdated Nov 22, 2026
Total Assets
199.61BJPY
1.25B · vs all stocks (USD)
FY2026 · Mar 31, 2026
Total Current Assets
93.32BJPYFY2026 · Mar 31, 2026
Total Liabilities
83.69BJPYFY2026 · Mar 31, 2026
Total Non-current Assets
106.29BJPYFY2026 · Mar 31, 2026
Total Non-current Liabilities
23.28BJPYFY2026 · Mar 31, 2026
Total Current Liabilities
60.41BJPYFY2026 · Mar 31, 2026
Cash & Cash Equivalents
38.11BJPYFY2026 · Mar 31, 2026
Accounts Receivable
15.83BJPYFY2026 · Mar 31, 2026
Inventory
34.58BJPYFY2026 · Mar 31, 2026
Accounts Payable
41.87BJPYFY2026 · Mar 31, 2026
Short-term Debt
5.71BJPYFY2026 · Mar 31, 2026
Other Current Liabilities
7.60BJPYFY2026 · Mar 31, 2026
Long-term Debt
10.41BJPYFY2026 · Mar 31, 2026
Other Non-current Liabilities
879.00MJPYFY2026 · Mar 31, 2026
Common Stock (Book)
13.00BJPYFY2026 · Mar 31, 2026
Retained Earnings
92.18BJPYFY2026 · Mar 31, 2026
Total Shareholders' Equity
115.92BJPY
725.91M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Treasury Stock
4.36BJPYFY2026 · Mar 31, 2026
52-Week Low
2.79KJPYUpdated Nov 22, 2026
52-Week High
4.21KJPYUpdated Nov 22, 2026
52-Week Change
31.01%
vs all stocks
Updated Nov 22, 2026
Beta
0.1640x
vs all stocks
Updated Nov 22, 2026
50-Day MA
3.91KJPYUpdated Nov 22, 2026
200-Day MA
3.43KJPYUpdated Nov 22, 2026
Avg 10-Day Volume
41.80KSharesUpdated Nov 22, 2026
Avg 30-Day Volume
73.54KSharesUpdated Nov 22, 2026
Diluted EPS (TTM)
133.95JPYUpdated Nov 22, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.